Evidence map›Paper›PMID 40297771›Full record

ArticleJournal of pharmaceutical policy and practice2025

Analysis of clinical pharmacists' interventions in a rehabilitation setting.

Lina Naseralallah, Zahra Noureddine, Afif Ahmed, Moza Al Hail, Somaya Koraysh

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lina NaseralallahDepartment of Pharmacy, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0003-3035-1357
Zahra NoureddineDepartment of Pharmacy, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0001-9695-7293
Afif AhmedDepartment of Pharmacy, Hamad Medical Corporation, Doha, Qatar.
Moza Al HailDepartment of Pharmacy, Hamad Medical Corporation, Doha, Qatar.
Somaya KorayshDepartment of Pharmacy, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-2743-4496

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To elucidate the role of clinical pharmacists in rehabilitation programmes by examining the type, severity, medications involved, and the level of acceptance of pharmacists' interventions. Methods: A cross-sectional study was conducted at the Qatar Rehabilitation Institute (QRI) in Doha, Qatar. Clinical pharmacists' interventions and their underlying rationales were categorised by the type of intervention using a validated classification system. The severity of these interventions was assessed using the National Patient Safety Agency (NPSA) Risk Matrix. Linear regression and chi-square analyses were employed to examine the relationships between patient-related and medication-related characteristics and the pharmacist interventions. Results: A total of 3,807 clinical pharmacists' interventions involving 815 patients were collected and analysed. The majority of patients ( Conclusion: This study highlights the diverse roles of clinical pharmacists in the rehabilitation field. The unique complexity of rehabilitation patients creates a challenging environment for clinical pharmacists, requiring adherence to fundamental practice principles while customising approaches to address individual patient needs. Further research is needed to assess the impact of these interventions on clinically significant outcomes.

Indexed as

clinical pharmacistDrug-related problemsmedication managementpharmacist interventionsrehabilitation

Identifiers

PMID40297771
PMCPMC12035954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.